Atreca Inc (FRA:0C1)

€ 0.0435 -0.0715 (-62.17%) Market Cap: 2.93 Mil Enterprise Value: -15.66 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 0/100

Atreca Inc Phase 1b ATRC-101 Clinical Data Update Call Transcript

Jul 29, 2021 / 12:00PM GMT

Release Date Price: €4.18 (-36.18%)

Transcript 8-K10-Q

Operator

Ladies and gentlemen, welcome to the ATRC-101 Phase 1b initial data summary conference call. (Operator Instructions). I would now like to turn the conference over to your host, CEO, Mr. John Orwin. Sir, please go ahead.

John Orwin

Atreca, Inc. - President & CEO

Thank you very much, operator and thank you to all those joining us today. We are pleased to be hosting this conference call and webinar to present an initial data summary from the dose escalation portion of our Phase 1b trial of ATRC-101.

Joining me for the prepared remarks are Dr. Jonathan Benjamin, SVP of Clinical Research; and Dr. Tito Serafini, Chief Strategy Officer and Atreca Founder. Also on the line are Dr. [Lisha] Wang, SVP of Data Science and Informatics; Dr. Carl Millward, VP of Translational Medicine; and Herb Cross, CFO, who will be available during the Q&A session.

For those joining by phone, I'd note that we are presenting slides as part of today's program which can be viewed via the webcast. An archived replay of today's webcast and the accompanying slides

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.